Profile
Robert E.
Winkler worked as Vice President of Clinical Research & Development at Array BioPharma, Inc. He then worked as Vice President of Clinical Research & Operations at Amicus Therapeutics, Inc. from 2011 to 2013.
In 2018, he became the Chief Medical Officer at Zentalis Pharmaceuticals, Inc. Dr. Winkler received his undergraduate and doctorate degrees from The Hebrew University Hadassah Medical School.
Former positions of Robert E. Winkler
Companies | Position | End |
---|---|---|
ZENTALIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/03/2020 |
AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2013 |
ARRAY TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Robert E. Winkler
The Hebrew University Hadassah Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Robert E. Winkler